Shell Asset Management CO Sarepta Therapeutics, Inc. Transaction History

Shell Asset Management CO

$2.26 Billion
Q1 2024

A detailed history of Shell Asset Management CO transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Shell Asset Management CO holds 3,975 shares of SRPT stock, worth $602,133. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,975

Previous 4,115 3.4%

Holding current value

$602,133

Previous $397,000 29.72%

% of portfolio

0.02%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$93.7 - $141.53 $13,118 - $19,814	-140 Reduced 3.4%	3,975 $515,000
Q4 2023 Feb 14, 2024	SELL	$67.31 - $124.76 $82,925 - $153,704	-1,232 Reduced 23.04%	4,115 $397,000
Q3 2023 Nov 08, 2023	SELL	$102.5 - $123.59 $9,532 - $11,493	-93 Reduced 1.71%	5,347 $648,000
Q2 2023 Jul 28, 2023	BUY	$106.4 - $157.19 $115,976 - $171,337	1,090 Added 25.06%	5,440 $623,000
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $1,762 - $2,339	-15 Reduced 0.34%	4,350 $600,000

Q4 2022 Feb 07, 2023	SELL	$100.86 - $132.13 $88,756 - $116,274	-880 Reduced 16.78%	4,365 $566,000
Q3 2022 Nov 14, 2022	SELL	$75.71 - $119.24 $103,798 - $163,478	-1,371 Reduced 20.72%	5,245 $580,000
Q2 2022 Aug 09, 2022	BUY	$62.69 - $88.44 $71,153 - $100,379	1,135 Added 20.71%	6,616 $496,000
Q1 2022 May 04, 2022	SELL	$63.15 - $90.42 $51,277 - $73,421	-812 Reduced 12.9%	5,481 $428,000
Q4 2021 Feb 09, 2022	BUY	$77.28 - $99.42 $2,009 - $2,584	26 Added 0.41%	6,293 $567,000
Q3 2021 Nov 04, 2021	SELL	$65.97 - $92.48 $17,811 - $24,969	-270 Reduced 4.13%	6,267 $580,000
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $198,426 - $248,105	2,860 Added 77.78%	6,537 $508,000
Q1 2021 May 10, 2021	SELL	$72.25 - $168.95 $296,152 - $692,526	-4,099 Reduced 52.71%	3,677 $274,000
Q4 2020 Feb 16, 2021	BUY	$125.56 - $178.74 $20,466 - $29,134	163 Added 2.14%	7,776 $1.33 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $187,247 - $253,856	-1,473 Reduced 16.21%	7,613 $1.07 Million
Q2 2020 Aug 10, 2020	BUY	$93.0 - $171.7 $95,883 - $177,022	1,031 Added 12.8%	9,086 $1.46 Million
Q1 2020 May 11, 2020	SELL	$82.38 - $131.64 $139,798 - $223,393	-1,697 Reduced 17.4%	8,055 $788,000
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $140,968 - $249,738	1,842 Added 23.29%	9,752 $1.26 Million
Q3 2019 Nov 12, 2019	SELL	$72.81 - $156.91 $336,527 - $725,238	-4,622 Reduced 36.88%	7,910 $596,000
Q2 2019 Aug 12, 2019	SELL	$112.21 - $151.95 $16,943 - $22,944	-151 Reduced 1.19%	12,532 $1.9 Million
Q1 2019 May 09, 2019	BUY	$106.67 - $151.68 $635,646 - $903,861	5,959 Added 88.62%	12,683 $1.51 Million
Q4 2018 Feb 13, 2019	SELL	$97.32 - $148.76 $58,391 - $89,256	-600 Reduced 8.19%	6,724 $734,000
Q2 2018 Aug 10, 2018	SELL	$71.74 - $153.69 $28,050 - $60,092	-391 Reduced 5.07%	7,324 $968,000
Q4 2017 Feb 09, 2018	BUY	$47.64 - $56.75 $367,542 - $437,826	7,715	7,715 $429,000

Others Institutions Holding SRPT

# of Institutions

471

Shares Held

79.3M

Call Options Held

4.23M

Put Options Held

1.21M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $13.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Shell Asset Management CO with notifications on news.

Account

Shell Asset Management CO Sarepta Therapeutics, Inc. Transaction History